DTIC Hopes to Get Cannabis Master Plan Back on Track
The DTIC’s Cannabis and Hemp Steering Committee has met to try and get the Master Plan back on track. The DTIC has to date missed all its deadlines to draft a new cannabis commercialization policy and hopes to reignite the process.
African Cannabis Investors Looking for Measurable Returns Not Blue Sky Potential
Investors in African cannabis are measuring performance by verified turnover and export success rather than in cultivation licenses issued or potential processing capacity.
Rwanda’s Export-Only Cannabis Policy is Structured to Suit Big Pharma, But it’s Not Going Quite as Planned
Rwanda aims to be East Africa’s ‘Big Pharma’ cannabis hub, but its strategy locks out locals and benefits elites.
‘80% of SA Medical Cannabis Export Flower May be Finding its Way into the Illicit Local Retail Market’
Research confirms that SA’s licensed medical cannabis cultivators appear to be putting more flower into the illegal local market than they are exporting. Despite the fact that this is largely illegal, many growers are finding it easier, and more profitable, to supply the ‘Grey Zone’ than it is to crack the difficult EU market.
Americans Overwhelmingly Support Cannabis Legalization But Retail Access is Still a Major Issue for Consumers
88% of Americans support cannabis legalization, but only 53% live in states where consumption is legal. This has impacted retail patterns. Take the tiny town of New Buffalo, Michigan: it sells more cannabis than the whole of LA – because of its ease of access to neighbouring Illinois and Indiana where prohibition remains.
African Cultural Heritage Trust Project to Reintroduce Landrace Genetics to the Communities that Lost Them
In the face of growing threats to South Africa’s landrace varieties, the African Cultural Heritage Trust has initiated a bold programme to reintroduce indigenous cannabis genetics back into the communities they came from. Working with Druids Garden, the Trust has original genetic material dating back to the late 1940’s.
Pharmaceutical Society of SA: Section 21 is ‘Unsustainable’ as SAHPRA Chaos Spreads Beyond Medical Cannabis Access
SAHPRA’s Section 21 application process appears to have collapsed and the impact of the bureaucratic breakdown is having a knock on effect beyond medical cannabis access. The Pharmaceutical Society says the sector as a whole is experiencing severe supply chain disruptions requiring alternatives to registered medicine and Section 21 is not the answer.
SAHPRA Quietly Halts New Section 21 Medical Cannabis Approvals, Leaving Compliant Patients Without a Pathway
SAHPRA appears to have halted authorising all Section 21 medical cannabis applications for the past two months. This has created an uproar amongst genuine medical cannabis patients and service providers, who accuse SAHPRA of removing the only pathway to accessing medical cannabis without providing any alternative.
Kannelix Facilitates Farmer Training in Vaal Triangle Cannabis Commercialization Initiative
Cannabis mentoring company Kannelix has signed an MoU with the Vaal University of Technology to train 60 cannabis farmers in agro-processing and provide offtakes for their biomass. This is part of an MBOSA drive to mainstream traditional growers from the underground into the economic mainstream.
Angolan Investors Invited to Seek Out Opportunities in Botswana’s New Industrial and Medical Cannabis Sector
Batswana Cabinet Minister, Tiroyaone Ntsima says Angola’s business community should consider investing in Botswana’s new industrial and medicinal cannabis sector. Even though cannabis is illegal in Angola, Ntsima said Angolan investment in Botswana cannabis would enjoy the same protection rights as in any other market.